HAEMONETICS CORPORATION - DEF 14A

Company

HAEMONETICS CORP

Filed

June 12, 2018

Period of Report

July 26, 2018

Accession Number

0000313143-18-000033

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →